- Home
- IVVD vs ASM Comparison
IVVD vs ASM Comparison
Compare IVVD & ASM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- ASM
- Stock Information
- Founded
- IVVD 2020
- ASM 1968
- Country
- IVVD United States
- ASM Canada
- Employees
- IVVD N/A
- ASM N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- ASM Metal Mining
- Sector
- IVVD Health Care
- ASM Basic Materials
- Exchange
- IVVD Nasdaq
- ASM Nasdaq
- Market Cap
- IVVD 123.8M
- ASM 146.2M
- IPO Year
- IVVD 2021
- ASM N/A
- Fundamental
- Price
- IVVD $1.01
- ASM $1.37
- Analyst Decision
- IVVD Strong Buy
- ASM Strong Buy
- Analyst Count
- IVVD 4
- ASM 2
- Target Price
- IVVD $7.89
- ASM $1.85
- AVG Volume (30 Days)
- IVVD 8.5M
- ASM 1.6M
- Earning Date
- IVVD 03-27-2025
- ASM 03-11-2025
- Dividend Yield
- IVVD N/A
- ASM N/A
- EPS Growth
- IVVD N/A
- ASM 144.19
- EPS
- IVVD N/A
- ASM 0.02
- Revenue
- IVVD $11,564,000.00
- ASM $54,326,000.00
- Revenue This Year
- IVVD N/A
- ASM $55.38
- Revenue Next Year
- IVVD $599.08
- ASM $20.49
- P/E Ratio
- IVVD N/A
- ASM $53.86
- Revenue Growth
- IVVD N/A
- ASM 18.08
- 52 Week Low
- IVVD $0.36
- ASM $0.50
- 52 Week High
- IVVD $4.74
- ASM $1.56
- Technical
- Relative Strength Index (RSI)
- IVVD 46.50
- ASM 55.86
- Support Level
- IVVD $0.85
- ASM $1.17
- Resistance Level
- IVVD $1.27
- ASM $1.30
- Average True Range (ATR)
- IVVD 0.23
- ASM 0.09
- MACD
- IVVD -0.08
- ASM -0.01
- Stochastic Oscillator
- IVVD 12.80
- ASM 59.72
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About ASM Avino Silver & Gold Mines Ltd. (Canada)
Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.